CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 217 enrolled
Drug / intervention
IDP-122 Lotion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02514577
NCT02514577Phase 3Completed
CompareCT.gov

A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis

Bausch Health Americas, Inc.·interventional·Posted Aug 3, 2015·Updated Jan 27, 2020

In Brief

A Phase 3 clinical trial evaluating IDP-122 Lotion and IDP-122 Vehicle Lotion for Plaque Psoriasis. Completed, enrolled 217 participants across 15 sites.

Detailed Summary

This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \[IGA\] score of 3 or 4).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 3, 2015
Enrollment StartNov 7, 2015
Primary CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 10.9 years ago

Interventions

IDP-122 Lotiondrug

Topical lotion

IDP-122 Vehicle Lotiondrug

Topical lotion. No active ingredient.